Brian M. Stolz

2013

In 2013, Brian M. Stolz earned a total compensation of $1.2M as Senior Vice President and General Manager at Valeant Pharmaceuticals International.

Compensation breakdown

Non-Equity Incentive Plan$707,813
Salary$468,750
Other$9,876
Total$1,186,439

Stolz received $707.8K in non-equity incentive plan, accounting for 60% of the total pay in 2013.

Stolz also received $468.8K in salary and $9.9K in other compensation.

Rankings

In 2013, Brian M. Stolz's compensation ranked 5,884th out of 12,286 executives tracked by ExecPay. In other words, Stolz earned more than 52.1% of executives.

ClassificationRankingPercentile
All
5,884
out of 12,286
52nd
Division
Manufacturing
2,039
out of 4,612
56th
Major group
Chemicals And Allied Products
597
out of 1,462
59th
Industry group
Drugs
427
out of 1,156
63rd
Industry
Pharmaceutical Preparations
343
out of 890
62nd
Source: SEC filing on April 29, 2016.

Stolz's colleagues

We found seven more compensation records of executives who worked with Brian M. Stolz at Valeant Pharmaceuticals International in 2013.

2013

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2013

Laizer Kornwasser

Valeant Pharmaceuticals International

Group Chairman

2013

Daniel Wechsler

Valeant Pharmaceuticals International

Group Chairman

2013

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2013

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2013

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2013

Pavel Mirovsky

Valeant Pharmaceuticals International

President and General Manager, Europe

You may also like